Tenders/Request For Proposal (RFP) for Pharmacological testing of novel opioids, stimulants, and synthetic cannabinoids.

Open🇨🇦CanadaServices

Request For Proposal (RFP) for Pharmacological testing of novel opioids, stimulants, and synthetic cannabinoids.

Department of Health (HC)

Published: Aug 20, 2026

Updated: Aug 23, 2026

Source: CanadaBuys - Government of Canada

About This Opportunity

This is a services contract in the Research and health and medical services sectors, with a focus on Pharmaceuticals. Located in Canada, North America, this opportunity is open to firms and consortiums. Proposals must be submitted before September 18, 2026.

Published through CanadaBuys - Government of Canada, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for services in the Research sector. Service contracts are typically evaluated on both technical quality and price, and may require bidders to demonstrate relevant experience and qualified personnel. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Request For Proposal (RFP) for Pharmacological testing of novel opioids, stimulants, and synthetic cannabinoids. Novel psychoactive substances (NPS) in the illegal drug supply pose risks to Canadians. However, little is known about their pharmacological activity. More potent drugs increase the risk of overdose risks. Evidence on the pharmacological activity of these substances is essential to support scientific regulatory activities and risk assessments. The illegal drug supply is continuously evolving, with new substances continually being detected. There is a need for further information on their harms to Canadians. This procurement activity will allow for the evaluation of the in vitro pharmacological activity of three categories of emerging drugs: novel synthetic opioids, synthetic cannabinoids, and stimulants. The data generated from this contract will inform future assessment activities and allow the Office of Legislative and Regulatory Affairs (OLRA) to make more informed regulatory science decisions. For all three streams, they require the pharmacological testing of different classes of substances, and require acquisition of reference standards and control samples, getting licenses for controlled substances, conducting experiments (including doing statistical analysis), and finally drafting and finalizing reports. Canada is seeking offers from Offerors to provide Pharmacological Testing for Novel Opioids, Stimulants, and Synthetic Cannabinoids in three (3) separate streams to Health Canada. Stream 1 - In vitro pharmacological testing of emerging opioids at the Mu Opioid Receptor (MOR). Stream 2 – In vitro pharmacological testing of novel synthetic cannabinoids and Stream 3 – In vitro pharmacological testing of stimulant compounds. Each stream will be evaluated separately, and bidders are to provide their submissions for one (1) stream, two (2) streams or all three (3) streams. Up to three (3) contracts may be awarded under this request for. UNSPSC: *Drugs and Pharmaceutical Products (*51000000). Method: Competitive - Open bidding. Selection: Highest Combined Rating of Technical Merit and Price. Trade Agreements: *Canada-Colombia Free Trade Agreement *Canada-Peru Free Trade Agreement (CPFTA) *Canada-Panama Free Trade Agreement *Canada-European Union Comprehensive Economic and Trade Agreement (CETA) *Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP) *Canada-UK Trade Continuity Agreement (Canada-UK TCA) *World Trade Organization Agreement on Government Procurement (WTO GPA) *Canada-Honduras Free Trade Agreement *North American Free Trade Agreement (NAFTA) *Canada-Chile Free Trade Agreement (CCFTA) *Canada-Ukraine Free Trade Agreement (CUFTA) *Canada-Korea Free Trade Agreement (CKFTA) *Canadian Free Trade Agreement (CFTA). Regions: *Canada

Data provenance

This notice is sourced from CanadaBuys - Government of Canada and was originally published on August 20, 2026. Last refreshed today. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Department of Health (HC)

Department of Health (HC) has issued 17 procurement notices on BidsFactory, including 2 currently open and 5 awarded contracts. Activity concentrates in Health & Medical, Governance & Public Administration, and Research & Innovation. All notices are published for Canada. Notices are distributed via CanadaBuys - Government of Canada. Most recent publication: August 20, 2026.

Frequently asked questions about this tender

What type of contract is this?

This is a Services contract in the Research & Innovation sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in Canada. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit CanadaBuys - Government of Canada to access the full notice, required documents, and submission instructions provided by the contracting authority.

When does this tender close?

The submission deadline is September 18, 2026. You have 27 days left to prepare and submit your proposal to the contracting authority.

Who is the contracting authority?

This notice was issued by Department of Health (HC) in Canada. The authority is responsible for evaluating bids, awarding the contract, and managing performance.